Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about IL1A: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Gene page for IL1A encoding interleukin-1 alpha, a key pro-inflammatory cytokine in neurodegeneration
No AI portrait yet
| Gene Symbol | IL1A |
| Full Name | Interleukin 1 Alpha |
| Chromosome | 2q14.1 |
| Function | Unlike IL1B which is secreted as a mature protein, IL1A is active in both its pro-form and mature form. |
| Molecular Weight | 31 kDa |
| Pathways | NF-κB, MAPK |
| GeneCards | IL1A |
| Human Protein Atlas | IL1A |
| Associated Diseases | Als, Alzheimer, Inflammation |
| Interactions | ALZHEIMER, App, BACE1, BDNF, CANCER, CD14 |
| KG Connections | 198 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
flowchart TD
IL1A["IL1A"] -.->|"inhibits"| osteoblastogenesis["osteoblastogenesis"]
IL1A["IL1A"] -->|"activates"| PIEZO1["PIEZO1"]
IL1A["IL1A"] -->|"activates"| A1_ASTROCYTES["A1_ASTROCYTES"]
MICROGLIA["MICROGLIA"] -->|"expressed in"| IL1A["IL1A"]
IL1A["IL1A"] -->|"biomarker for"| Inflammation["Inflammation"]
IL1A["IL1A"] -->|"biomarker for"| Als["Als"]
IL1A["IL1A"] -->|"biomarker for"| Atherosclerosis["Atherosclerosis"]
IL1A["IL1A"] -->|"biomarker for"| Ms["Ms"]
IL1A["IL1A"] -->|"biomarker for"| Fibrosis["Fibrosis"]
IL1A["IL1A"] -.->|"inhibits"| Inflammation["Inflammation"]
IL1A["IL1A"] -->|"activates"| Senescence["Senescence"]
IL1A["IL1A"] -.->|"inhibits"| Cancer["Cancer"]
style IL1A fill:#4a1a6b,stroke:#333,color:#e0e0e0
style osteoblastogenesis fill:#1b5e20,stroke:#333,color:#e0e0e0
style PIEZO1 fill:#4a1a6b,stroke:#333,color:#e0e0e0
style A1_ASTROCYTES fill:#006494,stroke:#333,color:#e0e0e0
style MICROGLIA fill:#006494,stroke:#333,color:#e0e0e0
style Inflammation fill:#ef5350,stroke:#333,color:#e0e0e0
style Als fill:#ef5350,stroke:#333,color:#e0e0e0
style Atherosclerosis fill:#ef5350,stroke:#333,color:#e0e0e0
style Ms fill:#ef5350,stroke:#333,color:#e0e0e0
style Fibrosis fill:#ef5350,stroke:#333,color:#e0e0e0
style Senescence fill:#ef5350,stroke:#333,color:#e0e0e0
style Cancer fill:#ef5350,stroke:#333,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| PIEZO1 | activates | gene | 0.90 |
| osteoblastogenesis | inhibits | pathway | 0.90 |
| A1 astrocyte | causes | cell_type | 0.80 |
| ASTROCYTE | induces_a1_phenotype | cell_type | 0.80 |
| A1 astrocyte | inhibits | cell_type | 0.80 |
| RGC death | causes | biological_process | 0.80 |
| A1_ASTROCYTES | activates | cell_type | 0.72 |
| Senescence | activates | disease | 0.65 |
| Cancer | inhibits | disease | 0.65 |
| Longevity | inhibits | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Inflammation | inhibits | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Inflammation | biomarker_for | disease | 0.65 |
| Als | biomarker_for | disease | 0.65 |
| Atherosclerosis | biomarker_for | disease | 0.65 |
| Ms | biomarker_for | disease | 0.65 |
| Fibrosis | biomarker_for | disease | 0.65 |
| Ms | interacts_with | disease | 0.65 |
| Carcinoma | interacts_with | disease | 0.65 |
| Tumor | interacts_with | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Inflammation | associated_with | disease | 0.65 |
| ALS | biomarker_for | disease | 0.65 |
| IMMUNE_RESPONSE | activates | pathway | 0.60 |
| HTR3C | biomarker_for | gene | 0.60 |
| Nf-Κb | inhibits | pathway | 0.60 |
| Mtor | activates | pathway | 0.60 |
| CCR9 | biomarker_for | gene | 0.60 |
| CANCER | inhibits | gene | 0.60 |
| NTS | biomarker_for | gene | 0.60 |
| NR4A2 | biomarker_for | gene | 0.60 |
| CXCL2 | biomarker_for | gene | 0.60 |
| JAK1 | biomarker_for | gene | 0.60 |
| CSF2 | biomarker_for | gene | 0.60 |
| MMP9 | biomarker_for | gene | 0.60 |
| STAT3 | biomarker_for | gene | 0.60 |
| Oxidative Stress | therapeutic_target | pathway | 0.60 |
| INFLAMMATION | biomarker_for | gene | 0.60 |
| APP | therapeutic_target | gene | 0.60 |
| GSK3B | therapeutic_target | gene | 0.60 |
| IL6 | activates | gene | 0.60 |
| IL1B | therapeutic_target | gene | 0.60 |
| TFCP2 | associated_with | gene | 0.60 |
| ALZHEIMER | associated_with | gene | 0.60 |
| TNFRSF19 | biomarker_for | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| h-89500d80 | targets | hypothesis | 0.90 |
| OCULAR HYPERTENSION | upregulates | biological_process | 0.80 |
| MICROGLIA | secretes | cell_type | 0.80 |
| MICROGLIA | expressed_in | cell_type | 0.72 |
| MSR1 | biomarker_for | gene | 0.60 |
| CYTOKINES | inhibits | gene | 0.60 |
| INFLAMMATION | inhibits | gene | 0.60 |
| NF-ΚB | inhibits | gene | 0.60 |
| CANCER | inhibits | gene | 0.60 |
| OXIDATIVE STRESS | therapeutic_target | gene | 0.60 |
| AND | therapeutic_target | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | therapeutic_target | gene | 0.60 |
| GENES | therapeutic_target | gene | 0.60 |
| CCR9 | biomarker_for | gene | 0.60 |
| TNF | associated_with | gene | 0.60 |
| IFNG | associated_with | gene | 0.60 |
| IL6 | associated_with | gene | 0.60 |
| HIF1A | associated_with | gene | 0.60 |
| NFKB1 | associated_with | gene | 0.60 |
| BCL2 | therapeutic_target | gene | 0.60 |
| MAOB | therapeutic_target | gene | 0.60 |
| TNF | therapeutic_target | gene | 0.60 |
| SORL1 | associated_with | gene | 0.60 |
| MAPT | associated_with | gene | 0.60 |
| IDE | associated_with | gene | 0.60 |
| IL10 | associated_with | gene | 0.60 |
| PLAU | associated_with | gene | 0.60 |
| BACE1 | associated_with | gene | 0.60 |
| BDNF | associated_with | gene | 0.60 |
| NR4A2 | biomarker_for | gene | 0.60 |
| CXCL2 | biomarker_for | gene | 0.60 |
| CSF2 | biomarker_for | gene | 0.60 |
| STAT3 | biomarker_for | gene | 0.60 |
| MMP9 | biomarker_for | gene | 0.60 |
| JAK1 | biomarker_for | gene | 0.60 |
| HTR3C | biomarker_for | gene | 0.60 |
| NTS | biomarker_for | gene | 0.60 |
| LDLR | biomarker_for | gene | 0.60 |
| MAOA | therapeutic_target | gene | 0.60 |
| APP | therapeutic_target | gene | 0.60 |
| BDNF | therapeutic_target | gene | 0.60 |
| GFAP | therapeutic_target | gene | 0.60 |
| BAX | therapeutic_target | gene | 0.60 |
| IL1B | therapeutic_target | gene | 0.60 |
| GSK3B | therapeutic_target | gene | 0.60 |
| PECAM1 | interacts_with | gene | 0.60 |
| FOS | interacts_with | gene | 0.60 |
| FGF1 | interacts_with | gene | 0.60 |
| FGF5 | interacts_with | gene | 0.60 |
| RNA | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-03 | 7 hypotheses Top: 0.682
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning IL1A in their description or question text
No additional research found